Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMRA

IMARA (IMRA) Stock Price, News & Analysis

IMARA logo

About IMARA Stock (NASDAQ:IMRA)

Advanced Chart

Key Stats

Today's Range
$37.91
$38.80
50-Day Range
$6.32
$25.28
52-Week Range
$0.97
$6.32
Volume
9,704 shs
Average Volume
138,364 shs
Market Capitalization
$1.01 billion
P/E Ratio
772.75
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter.

IMRA Stock News Headlines

Could This Be the End of Retirement Worries?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
Imara Blume
Imara Announces Stockholder Approval of Merger With Enliven
See More Headlines

IMRA Stock Analysis - Frequently Asked Questions

IMARA Inc. (NASDAQ:IMRA) posted its quarterly earnings results on Tuesday, November, 9th. The company reported ($2.20) earnings per share for the quarter, beating analysts' consensus estimates of ($3.64) by $1.44.

IMARA's stock reverse split on Friday, February 24th 2023.The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

IMARA (IMRA) raised $76 million in an initial public offering (IPO) on Thursday, March 12th 2020. The company issued 4,500,000 shares at $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include NIO (NIO), Novavax (NVAX), NVIDIA (NVDA), Axsome Therapeutics (AXSM), Alibaba Group (BABA), AMC Entertainment (AMC) and BioXcel Therapeutics (BTAI).

Company Calendar

Last Earnings
11/09/2021
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMRA
CIK
1672619
Phone
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.05
Trailing P/E Ratio
772.75
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
2.12%
Return on Assets
2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
48.98
Quick Ratio
48.98

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.51 per share
Price / Cash Flow
75.24
Book Value
$3.44 per share
Price / Book
11.23

Miscellaneous

Outstanding Shares
26,234,000
Free Float
16,449,000
Market Cap
$1.01 billion
Optionable
Not Optionable
Beta
1.09

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:IMRA) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners